RS-1636

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRS-1636
Drug Alias NameMAO-A inhibitors (Sankyo)MAO-B inhibitors (Sankyo)RS-1636RS-1653
ClassificationSmall molecules
Mechanisms of ActionMonoamine oxidase B inhibitorsMonoamine oxidase A inhibitors
TargetsMonoamine oxidase BMonoamine oxidase A
Therapy Area/IndicationsDepressionParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsDepressionParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A